BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29661421)

  • 1. Liver Transplantation Using Prolonged Cold Ischemia Time Grafts Preserved With Institute George-Lopez-1 Solution.
    Wiederkehr JC; Igreja MR; Gonçalves N; Nogara M; Godoy M; Drago C; Massutti AM; Wiederkehr HA; Wiederkehr BA
    Transplant Proc; 2018 Apr; 50(3):711-713. PubMed ID: 29661421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of IGL-1 preservation solution in liver transplantation.
    Wiederkehr JC; Igreja MR; Nogara MS; Goncalves N; Montemezzo GP; Wiederkehr HA; Wassen MP; Nobrega HA; Zenatti KB; Mori LY; Tudisco MS
    Transplant Proc; 2014; 46(6):1809-11. PubMed ID: 25131043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Georges Lopez Institute Preservation Solution IGL-1 in Pancreas Transplantation: A Series of 47 Cases.
    Igreja MR; Wiederkehr JC; Wiederkehr BA; Maykon Massutti A; de Aguiar Wiederkehr H
    Transplant Proc; 2018 Apr; 50(3):702-704. PubMed ID: 29661420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graft Protection Against Cold Ischemia Preservation: An Institute George Lopez 1 and Histidine-tryptophan-ketoglutarate Solution Appraisal.
    Panisello-Rosello A; Castro-Benítez C; Lopez A; Balloji S; Folch-Puy E; Adam R; Roselló-Catafau J
    Transplant Proc; 2018 Apr; 50(3):714-718. PubMed ID: 29661422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type of donor aortic preservation solution and not cold ischemia time is a major determinant of biliary strictures after liver transplantation.
    Pirenne J; Van Gelder F; Coosemans W; Aerts R; Gunson B; Koshiba T; Fourneau I; Mirza D; Van Steenbergen W; Fevery J; Nevens F; McMaster P
    Liver Transpl; 2001 Jun; 7(6):540-5. PubMed ID: 11443584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoprotective Mechanisms in Fatty Liver Preservation against Cold Ischemia Injury: A Comparison between IGL-1 and HTK.
    Panisello-Roselló A; Verde E; Lopez A; Flores M; Folch-Puy E; Rolo A; Palmeira C; Hotter G; Carbonell T; Adam R; Roselló-Catafau J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Benefits of Hypothermic Machine Preservation and Short Cold Ischemia Times in Deceased Donor Kidneys.
    Kox J; Moers C; Monbaliu D; Strelniece A; Treckmann J; Jochmans I; Leuvenink H; Van Heurn E; Pirenne J; Paul A; Ploeg R
    Transplantation; 2018 Aug; 102(8):1344-1350. PubMed ID: 29570164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cold Ischemia Time on the Function of Liver Grafts Preserved With Custodiol.
    Rodrigues MG; Castro PMV; Almeida TC; Danziere FR; Sergi Filho FA; Zeballos Sempertegui BE; Branez JR; Mota LT; Perosa de Miranda M; Gomes Dos Santos R; Genzini T
    Transplant Proc; 2021 Mar; 53(2):661-664. PubMed ID: 33139037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Direct Comparison Between Institut Georges Lopez 1 and Histidine-Tryptophan-Ketoglutarate Preservation Solutions in Liver Transplantation.
    Kiyoshi Takano de Saidneuy AE; Bruno de Rezende M; Rogerio de Oliveira Salvalaggio P
    Transplant Proc; 2020 Jun; 52(5):1262-1264. PubMed ID: 32507487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation.
    Piratvisuth T; Tredger JM; Hayllar KA; Williams R
    Liver Transpl Surg; 1995 Sep; 1(5):296-301. PubMed ID: 9346586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study comparing IGL-1 to the University of Wisconsin preservation solution in liver transplantation.
    Dondéro F; Paugam-Burtz C; Danjou F; Stocco J; Durand F; Belghiti J
    Ann Transplant; 2010; 15(4):7-14. PubMed ID: 21183870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuin 1 in rat orthotopic liver transplantation: an IGL-1 preservation solution approach.
    Pantazi E; Zaouali MA; Bejaoui M; Folch-Puy E; Ben Abdennebi H; Varela AT; Rolo AP; Palmeira CM; Roselló-Catafau J
    World J Gastroenterol; 2015 Feb; 21(6):1765-74. PubMed ID: 25684941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver graft preservation using perfluorocarbon improves the outcomes of simulated donation after cardiac death liver transplantation in rats.
    Okumura S; Uemura T; Zhao X; Masano Y; Tsuruyama T; Fujimoto Y; Iida T; Yagi S; Bezinover D; Spiess B; Kaido T; Uemoto S
    Liver Transpl; 2017 Sep; 23(9):1171-1185. PubMed ID: 28650112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Institut Georges Lopez-1 and Celsior preservation solutions on liver graft injury.
    Tabka D; Bejaoui M; Javellaud J; Roselló-Catafau J; Achard JM; Abdennebi HB
    World J Gastroenterol; 2015 Apr; 21(14):4159-68. PubMed ID: 25892865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rewarming preservation by organ perfusion system for donation after cardiac death liver grafts in pigs.
    Matsuno N; Obara H; Watanabe R; Iwata S; Kono S; Fujiyama M; Hirano T; Kanazawa H; Enosawa S
    Transplant Proc; 2014 May; 46(4):1095-8. PubMed ID: 24815137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation.
    Jain A; Mohanka R; Orloff M; Abt P; Kashyap R; Cullen J; Lansing K; Bozorgzadeh A
    Exp Clin Transplant; 2006 Jun; 4(1):451-7. PubMed ID: 16827642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American results.
    Selzner M; Goldaracena N; Echeverri J; Kaths JM; Linares I; Selzner N; Serrick C; Marquez M; Sapisochin G; Renner EL; Bhat M; McGilvray ID; Lilly L; Greig PD; Tsien C; Cattral MS; Ghanekar A; Grant DR
    Liver Transpl; 2016 Nov; 22(11):1501-1508. PubMed ID: 27339754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relevance of the UPS in Fatty Liver Graft Preservation: A New Approach for IGL-1 and HTK Solutions.
    Panisello-Roselló A; Verde E; Amine Zaouali M; Flores M; Alva N; Lopez A; Folch-Puy E; Carbonell T; Hotter G; Adam R; Roselló-Catafau J
    Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29088097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of organ preservation with University of Wisconsin solution.
    D'Alessandro AM; Kalayoglu M; Sollinger HW; Pirsch JD; Southard JH; Belzer FO
    Arch Pathol Lab Med; 1991 Mar; 115(3):306-10. PubMed ID: 2001173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative prospective study of two liver graft preservation solutions: University of Wisconsin and Celsior.
    Lopez-Andujar R; Deusa S; Montalvá E; San Juan F; Moya A; Pareja E; DeJuan M; Berenguer M; Prieto M; Mir J
    Liver Transpl; 2009 Dec; 15(12):1709-17. PubMed ID: 19938119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.